Meet the clinicians prescribing cannabis medicines, clinics using ketamine off-label and patients whose lives have been transformed by plant medicine. Join our thought leaders who will be giving insight into how they treat particular illnesses, recommend products, and embark on educational programmes for both patients and fellow doctors alike.

The psychedelic industry is growing at breakneck speed, built on the back of tremendous clinical breakthroughs and the growing prominence of psychedelic-assisted therapies. Increasingly, studies on well-known compounds – such as MDMA, LSD, Ayahuasca, Psilocybin – have paved the way for the biggest breakthroughs in mental health for a generation, with innovative organisations developing additional novel compounds to tackle traditionally treatment-resistant conditions. Join this conference to learn about the latest research developments, innovative businesses, investment opportunities, patient access, ceremonial rituals and the psychedelic pioneers that the industry is built upon.

With a plethora of differing regulatory regimes and an ever-changing policy landscape – even across trading blocks, like the EU – find out how best to operate internationally, meet local partners suitable for your organisation, and glean the key info that will keep you compliant.

As the retail landscape was turned on its head by the global pandemic, there’s never been a more significant moment for consumer brands. Having to contend with ever-changing regulations, the fall of brick-and-mortar retail, supply chain breakdowns, and the necessity for a robust, digital presence, many brands have had a sink-or-swim moment. Those who have been able to navigate the tide are well placed to thrive as the world comes back to ‘normal’. Join this conference to learn about product development innovations, branding marketing strategies, best practice for engaging with retailers, and expanding operations cross-border.

Discover the latest cultivation techniques enabling LPs and boutique growers to optimise their outdoor, indoor and hybrid grow operations to boost sales. Moreover, explore how organisations are utilising tech to automate processes, to ensure consistent and stable production.

Despite the COVID pandemic, 2020 saw an exponential increase in both private and public investment activity, across both cannabis and psychedelics. This trend has gone into overdrive in 2021, with record numbers of businesses listing publicly and retail investors increasingly able to have exposure to the markets. Much of this has been driven by regulatory and governmental changes, giving investors further confidence that the winds are blowing in the right direction. Join this conference to learn from industry analysts, investment houses and leading business giving insights on deploying capital, navigating regulations, and discussing what’s hot, what’s not and what’s next.